1-2厘米肾结石行微型经皮肾镜取石术或输尿管软镜碎石术的结局与费用:一项前瞻性随机临床试验数据
该研究为两组平行随机对照试验,纳入51例微型经皮肾镜取石术和50例输尿管软镜碎石术患者,比较1-2厘米肾结石的治疗结局。以2毫米残留结石负荷为界,微型经皮肾镜取石术组的无结石率更高(76% vs 46%,P=0.0023),但透视时间更长、住院时间更长、净收入和直接成本更高;两组并发症、手术时间和经营利润率无显著差异。
要点
- 以2毫米为界,微型经皮肾镜取石术无结石率76% vs 输尿管软镜46%,P=0.0023。
- 输尿管软镜组残留结石负荷更高(3.6 vs 1.4毫米,P=0.0026),微型经皮肾镜组透视时间更长(273 vs 49秒,P<0.0001)。
- 两组30天内并发症、30天内二次手术需求、肌酐变化、手术时间和经营利润率无显著差异。
核心结论
- 在采用2毫米残留结石负荷界值的前瞻性随机对照临床试验中,微型经皮肾镜取石术比输尿管软镜碎石术更可能使患者达到无结石状态,两组并发症、手术时间和经营利润率无差异。
研究设计与样本
- 两组平行随机对照试验,纳入51例微型经皮肾镜取石术患者和50例输尿管软镜碎石术患者,对象为1-2厘米肾结石成人患者,排除孤立肾、多发结石及妨碍俯卧位的合并症,采用区组随机化,手术当日早晨向术者揭晓分组。
主要发现
- 以2毫米为界,微型经皮肾镜取石术组无结石率76% vs 输尿管软镜组46%,P=0.0023。
- 输尿管软镜组残留结石负荷显著高于微型经皮肾镜取石术组(3.6 vs 1.4毫米,P=0.0026)。
- 微型经皮肾镜取石术组透视时间显著更高(273 vs 49秒,P<0.0001)。
- 两组30天内术后并发症、30天内二次手术必要性及术前至术后肌酐变化无差异(P>0.05),手术时间无显著差异(P=0.1788)。
- 微型经皮肾镜取石术组平均住院时间更高(P<0.0001),净收入和直接成本均更高(P<0.05),但两者相抵后经营利润率无显著差异(P=0.2541)。
关键数值与推荐
- 无结石率以术后1-30天计算机断层扫描评估,采用2毫米残留结石负荷界值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluate the outcomes of ureteroscopy vs prone mini-percutaneous nephrolithotomy for 1-2-cm renal stones using a 2-group parallel randomized control trial. MATERIALS AND METHODS: Adult patients presenting with renal stones between 1 and 2 cm were randomized. Exclusion criteria included solitary kidney, multiple stones, and comorbidities precluding prone positioning. Block randomization was performed and was opened to the surgeon the morning of the procedure. Stone-free rate was evaluated by computed tomography 1-30 days postoperatively. Complications, re-treatment rates, and costs were evaluated. RESULTS: A total of 51 mini-percutaneous nephrolithotomy and 50 ureteroscopy patients were included. Baseline demographics were similar. Using a 2-mm cutoff, stone-free rate was higher in the mini-percutaneous nephrolithotomy group (76 vs 46%, P = .0023). The residual stone burden was significantly higher in the ureteroscopy group than the mini-percutaneous nephrolithotomy group (3.6 vs 1.4 mm, P = .0026). Fluoroscopy time was significantly higher in the mini-percutaneous nephrolithotomy group (273 vs 49 seconds, P < .0001). There were no differences in postoperative complications within 30 days, the necessity of a secondary procedure within 30 days, and pre- to postoperative creatinine change (P > .05). Surgical time did not vary significantly (P = .1788). Average length of stay was higher in the mini-percutaneous nephrolithotomy group (P < .0001). Both net revenue and direct costs were higher in mini-percutaneous nephrolithotomy procedures (P < .05), though they offset each other with a nonsignificant operating margin (P = .2541). CONCLUSIONS: In a prospective, randomized, controlled clinical trial using a 2-mm residual stone burden cutoff, mini-percutaneous nephrolithotomy was more likely to render patients stone-free than flexible ureteroscopy. Complications, surgical times, and operating margins did not vary between the approaches.
引用
- Dutta R, Mithal P, Klein I, et al. Outcomes and Costs Following Mini-percutaneous Nephrolithotomy or Flexible Ureteroscopic Lithotripsy for 1-2-cm Renal Stones: Data From a Prospective, Randomized Clinical Trial. J Urol. 2023. PMID: 37157794. doi:10.1097/JU.0000000000003397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。